New York Fen-Phen Attorneys

Our firm provides the highest level of legal expertise for drug related injury cases in New York. Our New York pharmaceutical litigation attorneys represent individuals and families of those injured or killed as a result of negligence committed by physicians, drug manufacturers, pharmacists and other health care providers. We handle all drug related injury cases including Duract, Ephedra, Fen-Phen, Lotronex, Posicor, PPA, Propulsid, Rezulin and Trovan.

Fen-Phen, also known as Redux, pondimin, fenfluramine, dexfenfluramine, phentermine was manufactured by Wyeth-Ayerst as a weight loss drug and prescribed to millions of consumers until it was withdrawn from the market in September, 1997. It was discovered that Fen-Phen could cause a potentially serious and unusual form of valvular heart disease known as PPH - primary pulmonary hypertension, an often fatal disorder.

The symptoms of this disease may include dyspnea, reduced exercise tolerance and/or lower extremity edema.

If you or a loved one have suffered a drug related injury, the attorneys at Wingate, Russotti & Shapiro, L.L.P., would like to meet with you. Please call our office at 212-986-7353 to set up an appointment to discuss your case.

An attorney client relationship is not established by submitting this initial contact information.

420 Lexington Avenue
Suite 2750
New York, NY 10170

Telephone: 212-986-7353
Fax: 212-953-4308
E-mail: wrs@wrslaw.com